AsprevaLifeSciences British Columbia, the industry association representing the province’s biotech, medical device and greater life sciences community is pleased to extend our congratulations to Dr. Michael Hayden on being selected as the recipient of the 2007 Prix Galien. The Prix Galien is one of the biopharmaceutical world’s most prestigious awards, and will be presented to Dr. Hayden at a gala ceremony in Montreal this week. Dr. Hayden is Director and Senior Scientist at the University of British Columbia’s Centre for Molecular Medicine and Therapeutics, the Canada Research Chair in Human Genetics and Molecular Medicine, and University Killam Professor, Department of Medical Genetics, UBC. He is also a successful entrepreneur, co-founding multiple successful British Columbia-based biotechnology companies including Aspreva Pharmaceuticals and Xenon Pharmaceuticals. Continue reading "Dr. Michael Hayden Awarded 2007 Prix Galien"